ADC Therapeutics SA (NYSE:ADCT) Q4 2022 Earnings Call Transcript

Operator: Welcome to the ADC Therapeutics Fourth Quarter and Full Year 2022 Financial Results Conference Call. My name is Andrew, and I'll be your operator for today's call.

Keep Reading →